Total raised
—
Last: Seed 2019-11
Stage
Seed
Founded
2019
Headcount
6
HQ
Sector
Health Tech & Life Sciences
About
Nevrox is a drug discovery company developing a neuroprotective small molecule modulator of protein disulfide isomerase (PDI) for the treatment of Huntingtons disease (HD) and amyotrophic lateral sclerosis (ALS). The company is part of the FuturX biotech incubator in Ness Ziona.
Funding history · 1 round · — total
2019-11
Seed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
degenerative-diseasestreatmentsbiotechnologyneurologypharmaceuticalsdrug-discoverypharma-companiesamyotrophic-lateral-sclerosis-als